Login

Diversey IPO Preview with CEO Phil Wieland | Phil Wieland - CEO of Diversey Holdings 00:10:00

Share On Facebook Share On Twitter

Phil Wieland is the CEO of Diversey Holdings

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Dennis Vermillion, CEO of Avista Corp, delivered the keynote at the WSU Power Professorship 50th Anniversary Celebration, highlighting advancements in energy systems at the Energy Systems Innovation Center.
00:10:00
NovaGold: Advancing Donlin Gold Project with Strong Financials and Federal Permits
00:10:00
Q2 Market Update: Cautious Optimism Amid Global Uncertainty
00:10:00
Silver Hammer Mining Corp.: Building a Silver Producer with Strategic Acquisitions
00:10:00
Phunware CEO Alan Knitowski announces the formal closure of the acquisition of privately-held Lyte Technology, Inc. in an interview with Proactive.
00:10:00
Frank Tang on China's Path to Post-COVID Recovery and Business Resilience | Frank Tang, CEO, FountainVest Partners.
00:10:00
Kefi Minerals' Developments in Ethiopia and Saudi Arabia
00:10:00
Builders FirstSource CEO Dave Rush on Stock Performance, Housing Market Correlation, and the Impact of Rising Rates | Dave Rush, CEO, Builders FirstSource Inc.
00:10:00
Develop and launch solutions for challenges facing industries|Sean Smith,CEO,Eden Research
00:00:00
Michael Castagna, PharmD Chief Executive Officer, Maternus Kliniken
00:10:00
Legal Insights: Panel with Evan Chesler and NYU Law Professors | Evan R. Chesler - RETIRED PARTNER of Cravath, Swaine & Moore LLP
00:10:00
We take great pride in delving into each client’s unique situation investing the time to understand all of the details of your business.|Dean Zuccarello, CEO,The Cypress Group

© 2026 Nehu